Xiaoli Liu

机构：Weifang Medical University, Linyi People's Hospital · ORCID：0000-0002-2278-776X

发表论文 21 篇 · 总被引 153 次 · h-index 6

代表论文

• Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4 (2016 · International Journal of Molecular Medicine · 被引 46)
• Low Expression of Slit2 and Robo1 is Associated with Poor Prognosis and Brain-specific Metastasis of Breast Cancer Patients (2015 · Scientific Reports · 被引 38)
• Upregulation of miR‐886 indicates poor prognosis and promotes tumour progression of prostate cancer (2021 · Andrologia · 被引 15)
• Chlorogenic acid regulates the proliferation and migration of high-grade serous ovarian cancer cells through modulating the miR199a5p/DDR1 axis (2022 · Acta Biochimica Polonica · 被引 14)
• High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy (2021 · Frontiers in Oncology · 被引 13)
• Fully Convolutional Neural Network Deep Learning Model Fully in Patients with Type 2 Diabetes Complicated with Peripheral Neuropathy by High-Frequency Ultrasound Image (2022 · Computational and Mathematical Methods in Medicine · 被引 9)